Rewiring Endogenous Genes in CAR T Cells for Tumor-Restricted Payload Delivery

Researchers have developed a CRISPR knock-in strategy that leverages the regulatory mechanisms of endogenous genes to drive transgene expression in a tumor-localized manner.